Summary
16.70 -1.13(-6.31%)05/21/2024
Walgreens Boots Alliance Inc (WBA)
Walgreens Boots Alliance Inc (WBA)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.41 | -2.42 | -9.63 | -24.00 | -20.00 | -45.29 | -62.84 | 15,067.97 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 17.32 | |
| Open | 17.28 | |
| High | 17.57 | |
| Low | 17.25 | |
| Volume | 7,717,260 | |
| Change | 0.07 | |
| Change % | 0.41 | |
| Avg Volume (20 Days) | 7,060,096 | |
| Volume/Avg Volume (20 Days) Ratio | 1.09 | |
| 52 Week Range | 17.24 - 32.88 | |
| Price vs 52 Week High | -47.32% | |
| Price vs 52 Week Low | 0.46% | |
| Range | 0.23 | |
| Gap Up/Down | -0.64 | |
Fundamentals | ||
| Market Capitalization (Mln) | 14,390 | |
| EBIDTA | 5,352,999,936 | |
| PE Ratio | 16.8155 | |
| PEG Ratio | 12.0008 | |
| WallStreet Target Price | 52.97 | |
| Book Value | 27.0620 | |
| Earnings Per Share | 2.9330 | |
| EPS Estimate Current Quarter | 1.0100 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 4.7500 | |
| EPS Estimate Next Year | 5.0500 | |
| Diluted EPS (TTM) | 2.9330 | |
| Revenues | ||
| Profit Marging | 0.0192 | |
| Operating Marging (TTM) | 0.0277 | |
| Return on asset (TTM) | 0.0272 | |
| Return on equity (TTM) | 0.0864 | |
| Revenue TTM | 132,508,999,680 | |
| Revenue per share TTM | 153.2250 | |
| Quarterly Revenue Growth (YOY) | 0.1280 | |
| Quarterly Earnings Growth (YOY) | 0.6790 | |
| Gross Profit (TTM) | 28,067,000,000 | |
| Dividends | ||
| Dividend Share | 1.8800 | |
| Dividend Yield | 0.0383 | |
| Valuations | ||
| Trailing PE | 16.8155 | |
| Forward PE | 10.0908 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.8261 | |
| Revenue Enterprise Value | 0.5657 | |
| EBITDA Enterprise Value | 15.3838 | |
| Shares | ||
| Shares Outstanding | 863,945,024 | |
| Shares Float | 716,077,823 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 17.29 | |
| Institutions (%) | 58.12 | |
05/21 05:21 EST - fool.com
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Dividend-paying stocks have more than doubled up the annualized average return of non-payers over the last half-century. Although roughly 80% of S&P 500 companies pay a regular dividend, only a little over a dozen sport a truly supercharged yield.
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Dividend-paying stocks have more than doubled up the annualized average return of non-payers over the last half-century. Although roughly 80% of S&P 500 companies pay a regular dividend, only a little over a dozen sport a truly supercharged yield.
05/20 10:00 EST - zacks.com
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
05/20 09:56 EST - proactiveinvestors.co.uk
Work from home clampdown falters with rise in ‘coffee badging'
Companies' attempted clampdowns on home working has led to a rise in staff nipping in and out of offices in order to simply gain credit, research suggests. One in three people in the UK able to flexibly work admit to so-called “coffee badging”, according to Telegraph-cited research by hybrid working company Owl Labs.
Work from home clampdown falters with rise in ‘coffee badging'
Companies' attempted clampdowns on home working has led to a rise in staff nipping in and out of offices in order to simply gain credit, research suggests. One in three people in the UK able to flexibly work admit to so-called “coffee badging”, according to Telegraph-cited research by hybrid working company Owl Labs.
05/19 06:51 EST - fool.com
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?
Billionaire money managers bought millions of shares of high-yield healthcare stocks during the first three months of 2024. John Overdeck and David Siegel of Two Sigma Investments bought over 8 million Pfizer shares, and they weren't the only billionaires interested in the pharmaceutical giant.
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?
Billionaire money managers bought millions of shares of high-yield healthcare stocks during the first three months of 2024. John Overdeck and David Siegel of Two Sigma Investments bought over 8 million Pfizer shares, and they weren't the only billionaires interested in the pharmaceutical giant.
05/16 16:30 EST - investorplace.com
Buy the Dip: 3 Growth Stocks Poised for a Rapid Rebound
Finding stable investment options is essential for investors looking to grow despite market volatility in today's unpredictable environment. Three companies emerge as strong contenders for a swift recovery.
Buy the Dip: 3 Growth Stocks Poised for a Rapid Rebound
Finding stable investment options is essential for investors looking to grow despite market volatility in today's unpredictable environment. Three companies emerge as strong contenders for a swift recovery.
05/16 11:42 EST - forbes.com
Ex-Dividend Reminder: Nuvei, Walgreens And Johnson & Johnson
On 5/20/24, Nuvei, Walgreens Boots Alliance, and Johnson & Johnson will all trade ex-dividend for their respective upcoming dividends. Nuvei will pay its quarterly dividend of $0.10 on 6/6/24, Walgreens Boots Alliance will pay its quarterly dividend of $0.25 on 6/12/24, and Johnson & Johnson will pay its quarterly dividend of $1.24 on 6/4/24.
Ex-Dividend Reminder: Nuvei, Walgreens And Johnson & Johnson
On 5/20/24, Nuvei, Walgreens Boots Alliance, and Johnson & Johnson will all trade ex-dividend for their respective upcoming dividends. Nuvei will pay its quarterly dividend of $0.10 on 6/6/24, Walgreens Boots Alliance will pay its quarterly dividend of $0.25 on 6/12/24, and Johnson & Johnson will pay its quarterly dividend of $1.24 on 6/4/24.
05/16 05:15 EST - fool.com
Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks?
Walgreens Boots Alliance's problems go back years as it continues to post underwhelming top and bottom-line numbers. Boeing's quality control issues are serious as the company is losing the trust of customers, passengers, and investors.
Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks?
Walgreens Boots Alliance's problems go back years as it continues to post underwhelming top and bottom-line numbers. Boeing's quality control issues are serious as the company is losing the trust of customers, passengers, and investors.
05/15 09:53 EST - reuters.com
Walgreens launches own brand of opioid overdose reversal drug
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC).
Walgreens launches own brand of opioid overdose reversal drug
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC).
05/15 09:30 EST - forbes.com
Is Walgreens Stock Undervalued At $18?
Walgreens saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers for the Boots business. [1] Boots is a UK-based drugstore chain, and it could be valued at around $9 billion.
Is Walgreens Stock Undervalued At $18?
Walgreens saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers for the Boots business. [1] Boots is a UK-based drugstore chain, and it could be valued at around $9 billion.
05/15 08:00 EST - cnbc.com
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than over-the-counter Narcan nasal spray.
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than over-the-counter Narcan nasal spray.
05/15 08:00 EST - businesswire.com
Walgreens Brand Naloxone Available Online and In Stores This Month
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray. The product—which retails for $34.99, a lower price than the comparable national brand product at Walgreens stores, can reverse an overdose from opioids. The product is currently available online and will be chainwide in all stores by the end of the month, where it can be found in the pain aisle, providing.
Walgreens Brand Naloxone Available Online and In Stores This Month
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray. The product—which retails for $34.99, a lower price than the comparable national brand product at Walgreens stores, can reverse an overdose from opioids. The product is currently available online and will be chainwide in all stores by the end of the month, where it can be found in the pain aisle, providing.
05/14 18:51 EST - zacks.com
Walgreens Boots Alliance (WBA) Outperforms Broader Market: What You Need to Know
Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.
Walgreens Boots Alliance (WBA) Outperforms Broader Market: What You Need to Know
Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.
05/14 11:00 EST - investorplace.com
Blue-Chip Blues: 3 Stocks to Ditch Before They Drag You Down
Blue-chip stocks to sell might seem odd, especially in a year with rising corporate earnings, a U.S. presidential election and possibly three rate cuts. However, stock investors must stay watchful, especially with the S&P 500 and Dow Jones Industrial Average up 10% and 4.7%, respectively, far from a bull run.
Blue-Chip Blues: 3 Stocks to Ditch Before They Drag You Down
Blue-chip stocks to sell might seem odd, especially in a year with rising corporate earnings, a U.S. presidential election and possibly three rate cuts. However, stock investors must stay watchful, especially with the S&P 500 and Dow Jones Industrial Average up 10% and 4.7%, respectively, far from a bull run.
05/14 09:30 EST - businesswire.com
Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount for Memorial Day Friday, May 24 through Monday, May 27
DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a Memorial Day weekend discount to all veterans, active-duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country. Beginning May 24 through May 27, customers with a myWalgreens® membership and valid military ID or proof of service will receive 20 percent off regularly priced pro.
Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount for Memorial Day Friday, May 24 through Monday, May 27
DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a Memorial Day weekend discount to all veterans, active-duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country. Beginning May 24 through May 27, customers with a myWalgreens® membership and valid military ID or proof of service will receive 20 percent off regularly priced pro.
05/14 06:08 EST - investorplace.com
3 Beaten-Down Stocks Ready to Bounce Back Hard
Adversity frequently presents chances for recovery and expansion in the stock market. Following recent market declines, three equities have emerged as strong candidates for recovery.
3 Beaten-Down Stocks Ready to Bounce Back Hard
Adversity frequently presents chances for recovery and expansion in the stock market. Following recent market declines, three equities have emerged as strong candidates for recovery.
05/13 18:34 EST - fool.com
Why Walgreens Boots Alliance Stock Crushed the Market Today
A media report stated that the pharmacy-chain operator is in talks to sell a core asset. At one point, that business unit apparently could have fetched nearly $9 billion.
Why Walgreens Boots Alliance Stock Crushed the Market Today
A media report stated that the pharmacy-chain operator is in talks to sell a core asset. At one point, that business unit apparently could have fetched nearly $9 billion.
05/13 13:55 EST - investopedia.com
Walgreens Stock Jumps on Report It's Looking To Boot Boots
Walgreens Boots Alliance (WBA) shares jumped in intraday trading Monday following a report that the big drugstore chain has been reaching out to potential buyers of its British-based Boots unit.
Walgreens Stock Jumps on Report It's Looking To Boot Boots
Walgreens Boots Alliance (WBA) shares jumped in intraday trading Monday following a report that the big drugstore chain has been reaching out to potential buyers of its British-based Boots unit.
05/13 13:06 EST - forbes.com
Once Again, Walgreens May Try To Sell U.K. Boots Pharmacies
Walgreens Boots Alliance is once again attempting to sell its Boots pharmacies in the United Kingdom as the company chief executive officer Tim Wentworth and his new management team review the company's businesses.
Once Again, Walgreens May Try To Sell U.K. Boots Pharmacies
Walgreens Boots Alliance is once again attempting to sell its Boots pharmacies in the United Kingdom as the company chief executive officer Tim Wentworth and his new management team review the company's businesses.
05/13 12:15 EST - investorplace.com
Royalty No More: Time to Pounce or Flee From These 3 Stumbling Dividend Aristocrats?
Dividend Aristocrats are a unique class of dividend stocks. They are companies that are members of the S&P 500 and have increased their payouts to shareholders for at least 25 years.
Royalty No More: Time to Pounce or Flee From These 3 Stumbling Dividend Aristocrats?
Dividend Aristocrats are a unique class of dividend stocks. They are companies that are members of the S&P 500 and have increased their payouts to shareholders for at least 25 years.